Carbon-11-BU 99008

Drug Profile

Carbon-11-BU 99008

Alternative Names: [11C]BU99008; BU-99008

Latest Information Update: 25 Aug 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator GlaxoSmithKline; Imperial College of Science, Technology and Medicine
  • Class Diagnostic agents; Imaging agents
  • Mechanism of Action Positron-emission tomography enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase 0 Alzheimer's disease

Most Recent Events

  • 01 Jul 2016 Imperial College London in collaboration withGlaxoSmithKline initiates enrolment in a phase 0 trial for Alzheimer's disease (Diagnosis) in United Kingdom (NCT02874820)
  • 01 Dec 2014 Phase-0 for Alzheimer's disease (Diagnosis) in United Kingdom (IV) (NCT02323217)
  • 07 Apr 2014 Final pharmacokinetics data from a preclinical trial released by Imperial College London
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top